These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56. Amyotrophic lateral sclerosis: metabolism of central monoamines and treatment with L-dopa. Mendell JR; Chase TN; Engel WK Trans Am Neurol Assoc; 1971; 96():284-6. PubMed ID: 5159109 [No Abstract] [Full Text] [Related]
57. Statin use and risk of amyotrophic lateral sclerosis and other motor neuron disorders. Sørensen HT; Riis AH; Lash TL; Pedersen L Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):413-7. PubMed ID: 20530788 [TBL] [Abstract][Full Text] [Related]
58. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Stefan K; Kunesch E; Benecke R; Classen J Ann Neurol; 2001 Apr; 49(4):536-9. PubMed ID: 11310635 [TBL] [Abstract][Full Text] [Related]
59. [Treatment of amyotrophic lateral sclerosis with ribonucleotides]. Bunina TL; Khondkarian OA; Korshunova TS; Larskiĭ EG; Fuks BB Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):166-74. PubMed ID: 1266475 [TBL] [Abstract][Full Text] [Related]
60. Glial cells in ALS: the missing link? Raibon E; Todd LM; Möller T Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):441-59, vii-viii. PubMed ID: 18625409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]